(Q81888823)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15978705%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

title

Identification of DHBcAg as a potent carrier protein comparable to KLH for augmenting MUC1 antigenicity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15978705%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

John K Gathuru

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15978705%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Fusataka Koide

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15978705%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Govind Ragupathi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15978705%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Janet L Adams

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15978705%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Robnet T Kerns

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15978705%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Timothy P Coleman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15978705%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Philip O Livingston

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15978705%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

publication date

1 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15978705%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15978705%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15978705%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15978705%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

4727-4733

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15978705%20AND%20SRC:MED&resulttype=core&format=json

Philip Levine award lecture. Blood group antigens as markers for normal differentiation and malignant change in human tissues

13 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.007

Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.007

A short sequence, within the amino acid tandem repeat of a cancer-associated mucin, contains immunodominant epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.007

GD3/proteosome vaccines induce consistent IgM antibodies against the ganglioside GD3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.007

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.007

Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.007

Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.007

Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.007

Hepatitis B virus core particles as a vaccine carrier moiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.007

A virulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.007

The hepatitis nucleocapsid as a vaccine carrier moiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.007

Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.007

Preclinical evaluation of group B streptococcal polysaccharide conjugate vaccines prepared with a modified diphtheria toxin and a recombinant duck hepatitis B core antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.007

Comparison of antibody titers after immunization with monovalent or tetravalent KLH conjugate vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.007

The crystal structure of the human hepatitis B virus capsid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.007

Folding and assembly of hepatitis B virus core protein: a new model proposal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.007

Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.007

Evolutionary conservation in the hepatitis B virus core structure: comparison of human and duck cores.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.007

Mucosal immunogenicity of the hepatitis B core antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.007

Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.007

The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.007

10.1016/J.VACCINE.2005.05.007

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15978705%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference